Taiko Pharmaceutical Co.,Ltd.
4574
Rank in Stocks
#20522
Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector... Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
Share Price
$1.65
Last synced: 2026-11-10
Market Cap
$83.11M
Change (1 day)
0.38%
Change (1 year)
-12.47%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Taiko Pharmaceutical Co.,Ltd. (4574)
Category
Healthcare
EPS for Taiko Pharmaceutical Co.,Ltd. (4574)
EPS as of June 2026 TTM: $0.09
According to Taiko Pharmaceutical Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $0.09. At the end of 2025 the company had an EPS of $0.12, an increase over its 2024 EPS of $0.11.
EPS history for Taiko Pharmaceutical Co.,Ltd. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.09 | -27.75% |
| 2025 | $0.12 | 2.81% |
| 2024 | $0.11 | -121.07% |
| 2023 | $-0.54 | -36.83% |
| 2022 | $-0.86 | -55.31% |
| 2021 | $-1.92 | -321.74% |
| 2020 | $0.86 | 190.55% |
| 2019 | $0.30 | 22.45% |
| 2018 | $0.24 | 6.12% |
| 2017 | $0.23 | 18.43% |
| 2016 | $0.19 | -49.96% |
| 2015 | $0.39 | -12.11% |
| 2014 | $0.44 | 52.75% |
| 2013 | $0.29 | 92.25% |
| 2012 | $0.15 | -121.44% |
| 2011 | $-0.70 | -251.68% |
| 2010 | $0.46 | 268.08% |
| 2009 | $0.13 | -67.06% |
| 2008 | $0.38 | 11.52% |
| 2007 | $0.34 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 7,398.73% |
DE
|
|
| $6.08 | 6,909.92% |
DE
|
|
| $1.55 | 1,688.47% |
JP
|
|
| $3.66 | 4,121.45% |
CH
|
|
| $0.45 | 419.03% |
IL
|
Questions about Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS)
What is Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS)?
Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $0.09, as of Jun 2026.
What was Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) was $0.12, 9.09% more than in 2024 ($0.11).
How has Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) went from $0.86 to $0.12, an average decline of 32.56% a year.
How does Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
Taiko Pharmaceutical Co.,Ltd.'s earnings per share (EPS) ($0.09) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.